Foes of the 2.3% tax on medical device revenue have been making their case to lawmakers for years, and now they're looping in the workers who could be affected by the charge, hosting sessions to educate employees on what they can do support the repeal effort.
After a fiscal 2013 second quarter that grew like gangbusters, AngioDynamics warns that its third quarter numbers will come in below earlier, rosier projections. Investors reacted harshly, driving the stock down 12% in trading late Friday morning to just over $11.
AngioDynamics is spending $15 million to acquire minimally invasive microwave ablation technology from Microsulis Medical.
AngioDynamics is roaring into its 2013 fiscal year with soaring sales, driven by a boost from acquisitions, new products and also increased international demand.
The market for ablation devices stands to grow the most among all nonvascular interventional radiology devices in the U.S. over the next several years, the Millennium Research Group concludes in a new report.
AngioDynamics is back on the buyer's block, agreeing to pay $55 million over 5 years for Vortex Medical, maker of devices to remove clots from clogged vessels.
AngioDynamics ( $ANGO ) has agreed to buy rival Navilyst Medical, which focuses on vascular access, interventional radiology and interventional cardiology, in a deal valued at $372 million. The buy is...
AngioDynamics' ( $ANGO ) new CEO Joseph DeVivo is upbeat about his company's future even as its net income during the first quarter came in at $1.4 million, down from $1.9 million a year ago. The
A little more than a month after AngioDynamics ( $ANGO ) reported it had found its new CEO in Joseph DeVivo , Scott Solano, the company's senior VP and CTO, has announced he'll be stepping down
Switzerland's Endosense has named Jan Keltjens as president and CEO. He replaces Eric Le Royer, who is retiring from Endosense after leading the firm from its first venture capital financing 7 years